Please provide your email address to receive an email when new articles are posted on . Among patients who underwent a stress myocardial perfusion PET scan, increasing magnitude of stress myocardial ...

To detect in-stent restenosis among patients with coronary stents, a new study shows the potential for improved diagnostic accuracy by adding computed tomography perfusion imaging to coronary CT ...

The emerging advantages of positron-emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease (CAD) diagnosis and assessment of cardiovascular event risk has prompted ...

Patients who receive cardiac positron emission testing (PET) imaging instead of single photon emission computed tomography (SPECT) scan experienced a significant increase in the detection of severe ...

SmartHeart AI is a workflow planning solution designed to facilitate the application of tools within Philips’ broader cardiac MR suite.

A new radioactive tracer for positron emission tomography (PET) myocardial perfusion imaging will soon be available in the United States, and it’s expected to facilitate substantial growth in such ...

BARCELONA, Spain ― Artificial intelligence (AI) software substantially reduced false positives on myocardial perfusion imaging (MPI) for the diagnosis of coronary artery disease in high-risk patients, ...

The SmartHeart AI-powered MR workflow. [Image courtesy of Philips] Philips (NYSE: PHG) + announced today that it received FDA 510(k) clearance for its SmartHeart planning solution. SmartHeart, an ...

The significantly longer half-life of Flyrcado (109 minutes) allows for it to be manufactured at an offsite pharmacy and delivered as a ready-to-use unit dose. The approval was supported by data from ...

MONTREAL--(BUSINESS WIRE)--Jubilant DraxImage Inc., dba Jubilant Radiopharma, a wholly-owned subsidiary of Jubilant Pharma Limited, has entered into an exclusive partnership with Cardiac Imaging, Inc.